Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human PRAS40 ELISA Kit (AC3007)
Cat.#: ASET-1596
Specifications
Description Human PRAS40 ELISA Kit allows for the in vitro quantitative determination of human PRAS40 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1469 Mouse Choline Acetyltransferase ELISA Kit (AC2880) Quantitative inquiry ASET-2400 Human CDK5 ELISA Kit (AC3811) Quantitative inquiry ASET-2504 Rat 160 kD Neurofilament Medium ELISA Kit (AC3915) Quantitative inquiry ASET-1361 Sheep Inhibin beta B ELISA Kit (AC2772) Quantitative inquiry ASET-1237 Human NRXN3 ELISA Kit (AC2648) Quantitative inquiry ASET-2447 Human Neuropilin 1 ELISA Kit (AC3858) Quantitative inquiry ASET-2156 Sheep ENO2 ELISA Kit (AC3567) Quantitative inquiry ASET-2441 Camel Insulin ELISA Kit (AC3852) Quantitative inquiry ASET-1548 Human FLJ39155 ELISA Kit (AC2959) Quantitative inquiry ASET-1247 Human GSK3 beta ELISA Kit (AC2658) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket